Arcturus Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ARCT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Jun 24	SellUS$1,601,500	Andrew Sassine	Individual		50,000	US$32.03

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARCT?
Owner Type	Number of Shares	Ownership Percentage
General Public	549,671	2.03%
Individual Insiders	2,286,200	8.44%
Institutions	24,251,488	89.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.3%	Federated Hermes, Inc.	4,694,060	US$77.6m	0%	0.19%
10.9%	BlackRock, Inc.	2,952,013	US$48.8m	11.4%	no data
8.55%	Nikko Asset Management Co., Ltd.	2,315,294	US$38.3m	48.1%	0.01%
7.76%	ARK Investment Management LLC	2,101,038	US$34.7m	6.93%	0.24%
5.82%	The Vanguard Group, Inc.	1,576,926	US$26.1m	13.9%	no data
5.46%	Joseph Payne	1,480,097	US$24.5m	0%	no data
5.44%	State Street Global Advisors, Inc.	1,472,955	US$24.3m	-3.34%	no data
2.93%	Dimensional Fund Advisors LP	792,600	US$13.1m	-13.7%	no data
2.88%	Woodline Partners LP	779,956	US$12.9m	3.44%	0.11%
2.04%	Geode Capital Management, LLC	551,798	US$9.1m	1.06%	no data
1.64%	FMR LLC	442,981	US$7.3m	-20.3%	no data
1.61%	Padmanabh Chivukula	435,334	US$7.2m	-2.68%	no data
1.36%	Schonfeld Strategic Advisors LLC	369,599	US$6.1m	30.4%	0.05%
1.3%	Jupiter Fund Management Plc	351,977	US$5.8m	-0.16%	0.02%
1.2%	Goldman Sachs Group, Investment Banking and Securities Investments	325,350	US$5.4m	2.64%	no data
0.97%	Morgan Stanley, Investment Banking and Brokerage Investments	261,982	US$4.3m	-66.8%	no data
0.95%	UBS Asset Management AG	258,614	US$4.3m	-3.4%	no data
0.9%	JP Morgan Asset Management	243,623	US$4.0m	-5.97%	no data
0.9%	Northern Trust Global Investments	242,750	US$4.0m	5.4%	no data
0.87%	Millennium Management LLC	236,073	US$3.9m	-57.5%	no data
0.81%	Andrew Sassine	220,526	US$3.6m	0%	no data
0.81%	BioImpact Capital LLC	219,508	US$3.6m	0%	0.62%
0.73%	Charles Schwab Investment Management, Inc.	197,622	US$3.3m	1.66%	no data
0.58%	Bank of America Corporation, Asset Management Arm	157,237	US$2.6m	22.1%	no data
0.58%	Royce & Associates, LP	155,803	US$2.6m	18.3%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 06:53
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arcturus Therapeutics Holdings Inc. is covered by 22 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Huidong Wang	Barclays
Mayank Mamtani	B. Riley Securities, Inc.
Whitney Ijem	Canaccord Genuity